Evidence map›Paper›PMID 32440463›Full record

ArticleChemistryOpen2020

Porous Organic Polymers as Fire-Resistant Additives and Precursors for Hyperporous Carbon towards Oxygen Reduction Reactions.

Qingxia Xue, Wenjing Li, Jinli Dou, Weiiguo Song, Jingjing Ming, Weiwei Bian, Yuejuan Guo, Xinjian Li, Weifen Zhang, Baolong Zhou

Open access · goldAbstract read
In one paragraph

Article in ChemistryOpen, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Qingxia XueSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Wenjing LiSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Jinli DouSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Weiiguo SongSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Jingjing MingSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Weiwei BianSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Yuejuan GuoSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Xinjian LiSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Weifen ZhangSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.
Baolong ZhouSchool of pharmacy Weifang Medical University Weifang 261053, Shandong P. R. China.ORCID 0000-0001-7781-7842
Weifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclotriphosphazene (CP) based porous organic polymers (POPs) have been designed and prepared. The introduction of CP into the porous skeleton endowed special thermal stability and outstanding flame retardancy to prepared polymers. The nonflammable level of PNK-CMP fabricated via the condensation of 2,2'-(1,4-phenylene)diacetonitrile (DAN) and hexakis(4-acetylphenoxy)cyclotriphosphazene (HACTP) through Knoevenagel reaction, in vertical burning tests reached V-2 class (UL-94) and the limiting oxygen index (LOI) reached 20.8 %. When used as additive, PNK-CMP could suppress the dissolving out of PEPA effectively, reducing environment pollution and improving the flame retardant efficiency. The POP and PEPA co-added PU (m

Indexed as

cyclotriphosphazenefire-resistant additivehyperporous carbonsORRporous organic polymers

Identifiers

PMID32440463
PMCPMC7239271
OpenAlexW3028093209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.